Publications 2022

Frich PS, Sigstad E, Berstad AE, Fagerlid KH, Paulsen TH, Bjøro T, Flinder LI (2022)
Long-Term Efficacy of Ethanol Ablation as Treatment of Metastatic Lymph Nodes From Papillary Thyroid Carcinoma
J Clin Endocrinol Metab, 107 (5), e2141-e2147
DOI 10.1210/clinem/dgab907, PubMed 34922379

Huynh TTM, Aass HCD, Falk RS, Astrup GL, Helland Å, Bjøro T, Bjordal K, Dale E, Hellebust TP, Herlofson BB, Malinen E, Kiserud CE, Osnes T, Amdal CD (2022)
Associations between patient-reported late effects and systemic cytokines in long-term survivors of head and neck cancer treated with radiotherapy
J Cancer Surviv, 17 (4), 1082-1093
DOI 10.1007/s11764-022-01273-1, PubMed 36350483

Nome RV, Småstuen MC, Fosså SD, Kiserud CE, Åsvold BO, Bjøro T (2022)
Re: Thyroid hypofunction in aging testicular cancer survivors by Nome et al
Acta Oncol, 61 (3), 385
DOI 10.1080/0284186X.2021.2023214, PubMed 35037554

Publications 2021

Gehin JE, Klaasen RA, Norli ES, Warren DJ, Syversen SW, Goll GL, Bjøro T, Kvien TK, Mjaavatten MD, Bolstad N (2021)
Rheumatoid factor and falsely elevated results in commercial immunoassays: data from an early arthritis cohort
Rheumatol Int, 41 (9), 1657-1665
DOI 10.1007/s00296-021-04865-9, PubMed 33944985

Gehin JE, Warren DJ, Syversen SW, Lie E, Sexton J, Loli L, Wierød A, Bjøro T, Kvien TK, Bolstad N, Goll GL (2021)
Serum golimumab concentration and anti-drug antibodies are associated with treatment response and drug survival in patients with inflammatory joint diseases: data from the NOR-DMARD study
Scand J Rheumatol, 50 (6), 445-454
DOI 10.1080/03009742.2021.1875040, PubMed 33650469

Nome RV, Småstuen MC, Fosså SD, Kiserud CE, Åsvold BO, Bjøro T (2021)
Thyroid hypofunction in aging testicular cancer survivors
Acta Oncol, 60 (11), 1452-1458
DOI 10.1080/0284186X.2021.1958004, PubMed 34351829

Publications 2020

Nome RV, Cvancarova Småstuen M, Bjøro T, Kiserud CE, Fosså SD (2020)
Longitudinal kidney function outcome in aging testicular cancer survivors
Acta Oncol, 59 (4), 467-474
DOI 10.1080/0284186X.2020.1724328, PubMed 32043400

Publications 2019

Meuwese CL, van Diepen M, Cappola AR, Sarnak MJ, Shlipak MG, Bauer DC, Fried LP, Iacoviello M, Vaes B, Degryse J, Khaw KT, Luben RN, Åsvold BO, Bjøro T, Vatten LJ, de Craen AJM, Trompet S, Iervasi G, Molinaro S, Ceresini G, Ferrucci L, Dullaart RPF, Bakker SJL, Jukema JW, Kearney PM et al. (2019)
Low thyroid function is not associated with an accelerated deterioration in renal function
Nephrol Dial Transplant, 34 (4), 650-659
DOI 10.1093/ndt/gfy071, PubMed 29684213

Opsahl EM, Akslen LA, Schlichting E, Aas T, Brauckhoff K, Hagen AI, Rosenlund AF, Sigstad E, Grøholt KK, Jørgensen LH, Bjøro T (2019)
The Role of Calcitonin in Predicting the Extent of Surgery in Medullary Thyroid Carcinoma: A Nationwide Population-Based Study in Norway
Eur Thyroid J, 8 (3), 159-166
DOI 10.1159/000499018, PubMed 31259158

Publications 2018

Celestino R, Nome T, Pestana A, Hoff AM, Gonçalves AP, Pereira L, Cavadas B, Eloy C, Bjøro T, Sobrinho-Simões M, Skotheim RI, Soares P (2018)
CRABP1, C1QL1 and LCN2 are biomarkers of differentiated thyroid carcinoma, and predict extrathyroidal extension
BMC Cancer, 18 (1), 68
DOI 10.1186/s12885-017-3948-3, PubMed 29321030

Opsahl EM, Akslen LA, Schlichting E, Aas T, Brauckhoff K, Hagen AI, Rosenlund AF, Sigstad E, Grøholt KK, Mæhle L, Engebretsen LF, Jørgensen LH, Varhaug JE, Bjøro T (2018)
Trends in Diagnostics, Surgical Treatment, and Prognostic Factors for Outcomes in Medullary Thyroid Carcinoma in Norway: A Nationwide Population-Based Study
Eur Thyroid J, 8 (1), 31-40
DOI 10.1159/000493977, PubMed 30800639

Publications 2017

Broughton MN, Westgaard A, Paus E, Øijordsbakken M, Henanger KJ, Naume B, Bjøro T (2017)
Specific antibodies and sensitive immunoassays for the human epidermal growth factor receptors (HER2, HER3, and HER4)
Tumour Biol, 39 (6), 1010428317707436
DOI 10.1177/1010428317707436, PubMed 28653892

Nome RV, Bjøro T, Paus E, Bjerner J, Fosså SD, Steen R, Nustad K, Bolstad N (2017)
Lowered reference limits for hCG improve follow-up of patients with hCG-producing tumors
Clin Biochem, 52, 73-79
DOI 10.1016/j.clinbiochem.2017.11.016, PubMed 29198759

Seland M, Smeland KB, Bjøro T, Falk RS, Fosså SD, Gjesdal CG, Godang K, Holte H, Svartberg J, Syversen U, Bollerslev J, Kiserud CE (2017)
Bone mineral density is close to normal for age in long-term lymphoma survivors treated with high-dose therapy with autologous stem cell transplantation
Acta Oncol, 56 (4), 590-598
DOI 10.1080/0284186X.2016.1267870, PubMed 28077016

Publications 2016

Opsahl EM, Brauckhoff M, Schlichting E, Helset K, Svartberg J, Brauckhoff K, Mæhle L, Engebretsen LF, Sigstad E, Grøholt KK, Akslen LA, Jørgensen LH, Varhaug JE, Bjøro T (2016)
A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma
Thyroid, 26 (9), 1225-38
DOI 10.1089/thy.2015.0673, PubMed 27400880

Paur I, Lilleby W, Bøhn SK, Hulander E, Klein W, Vlatkovic L, Axcrona K, Bolstad N, Bjøro T, Laake P, Taskén KA, Svindland A, Eri LM, Brennhovd B, Carlsen MH, Fosså SD, Smeland SS, Karlsen AS, Blomhoff R (2016)
Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA
Clin Nutr, 36 (3), 672-679
DOI 10.1016/j.clnu.2016.06.014, PubMed 27406859

Reinertsen KV, Engebraaten O, Loge JH, Cvancarova M, Naume B, Wist E, Edvardsen H, Wille E, Bjøro T, Kiserud CE (2016)
Fatigue During and After Breast Cancer Therapy-A Prospective Study
J Pain Symptom Manage, 53 (3), 551-560
DOI 10.1016/j.jpainsymman.2016.09.011, PubMed 28042070

Aakre I, Strand TA, Bjøro T, Norheim I, Barikmo I, Ares S, Alcorta MD, Henjum S (2016)
Thyroid Function among Breastfed Children with Chronically Excessive Iodine Intakes
Nutrients, 8 (7)
DOI 10.3390/nu8070398, PubMed 27367720

Publications 2015

Broughton MN, Nome R, Sandven I, Paus E, Bjøro T (2015)
Characterization of a new highly sensitive immunometric assay for thyroglobulin with reduced interference from autoantibodies
Tumour Biol, 37 (6), 7729-39
DOI 10.1007/s13277-015-4597-2, PubMed 26695140

Fleiner HF, Bjøro T, Midthjell K, Grill V, Åsvold BO (2015)
Prevalence of Thyroid Dysfunction in Autoimmune and Type 2 Diabetes: The Population-Based HUNT Study in Norway
J Clin Endocrinol Metab, 101 (2), 669-77
DOI 10.1210/jc.2015-3235, PubMed 26583583

Seland M, Bjøro T, Furre T, Schreiner T, Bollerslev J, Fosså SD, Loge JH, Holte H, Kiserud CE (2015)
Hormonal dysfunction is frequent in cancer survivors treated with radiotherapy to the head and neck region
J Cancer Surviv, 9 (4), 630-40
DOI 10.1007/s11764-015-0439-x, PubMed 25750158

Seland M, Holte H, Bjøro T, Schreiner T, Bollerslev J, Loge JH, Fosså SD, Kiserud CE (2015)
Chronic fatigue is prevalent and associated with hormonal dysfunction in long-term non-Hodgkin lymphoma survivors treated with radiotherapy to the head and neck region
Leuk Lymphoma, 56 (12), 3306-14
DOI 10.3109/10428194.2015.1036258, PubMed 25827172

Sprauten M, Haugnes HS, Brydøy M, Kiserud C, Tandstad T, Bjøro T, Bjerner J, Cvancarova M, Fosså SD, Oldenburg J (2015)
Chronic fatigue in 812 testicular cancer survivors during long-term follow-up: increasing prevalence and risk factors
Ann Oncol, 26 (10), 2133-40
DOI 10.1093/annonc/mdv328, PubMed 26265167

Aakre I, Bjøro T, Norheim I, Strand TA, Barikmo I, Henjum S (2015)
Development of thyroid dysfunction among women with excessive iodine intake--A 3-year follow-up
J Trace Elem Med Biol, 31, 61-6
DOI 10.1016/j.jtemb.2015.03.004, PubMed 26004893

Åsvold BO, Vatten LJ, Bjøro T, Bauer DC, Bremner A, Cappola AR, Ceresini G, den Elzen WP, Ferrucci L, Franco OH, Franklyn JA, Gussekloo J, Iervasi G, Imaizumi M, Kearney PM, Khaw KT, Maciel RM, Newman AB, Peeters RP, Psaty BM, Razvi S, Sgarbi JA, Stott DJ, Trompet S, Vanderpump MP et al. (2015)
Thyroid function within the normal range and risk of coronary heart disease: an individual participant data analysis of 14 cohorts
JAMA Intern Med, 175 (6), 1037-47
DOI 10.1001/jamainternmed.2015.0930, PubMed 25893284

Publications 2014

Brauckhoff M, Machens A, Lorenz K, Bjøro T, Varhaug JE, Dralle H (2014)
Surgical curability of medullary thyroid cancer in multiple endocrine neoplasia 2B: a changing perspective
Ann Surg, 259 (4), 800-6
DOI 10.1097/SLA.0b013e3182a6f43a, PubMed 23979292

Kiserud CE, Seland M, Holte H, Fosså A, Fosså SD, Bollerslev J, Bjøro T, Loge JH (2014)
Fatigue in male lymphoma survivors differs between diagnostic groups and is associated with latent hypothyroidism
Acta Oncol, 54 (1), 49-59
DOI 10.3109/0284186X.2014.948057, PubMed 25140862

Nome R, Hernes E, Bogsrud TV, Bjøro T, Fosså SD (2014)
Changes in prostate-specific antigen, markers of bone metabolism and bone scans after treatment with radium-223
Scand J Urol, 49 (3), 211-7
DOI 10.3109/21681805.2014.982169, PubMed 25515952

Sprauten M, Brydøy M, Haugnes HS, Cvancarova M, Bjøro T, Bjerner J, Fosså SD, Oldenburg J (2014)
Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a population-based sample of long-term testicular cancer survivors
J Clin Oncol, 32 (6), 571-8
DOI 10.1200/JCO.2013.51.2715, PubMed 24419125

Aakre I, Bjøro T, Norheim I, Strand TA, Barikmo I, Henjum S (2014)
Excessive iodine intake and thyroid dysfunction among lactating Saharawi women
J Trace Elem Med Biol, 31, 279-84
DOI 10.1016/j.jtemb.2014.09.009, PubMed 25447589

Publications 2013

Asvold BO, Bjøro T, Vatten LJ (2013)
Associations of TSH levels within the reference range with future blood pressure and lipid concentrations: 11-year follow-up of the HUNT study
Eur J Endocrinol, 169 (1), 73-82
DOI 10.1530/EJE-13-0087, PubMed 23641017

Asvold BO, Vatten LJ, Bjøro T (2013)
Changes in the prevalence of hypothyroidism: the HUNT Study in Norway
Eur J Endocrinol, 169 (5), 613-20
DOI 10.1530/EJE-13-0459, PubMed 23975540

Sigstad E, Paus E, Bjøro T, Berner A, Grøholt KK, Jørgensen LH, Sobrinho-Simões M, Holm R, Warren DJ (2013)
Reply to 'The new molecular markers DDIT3, STT3A, ARG2 and FAM129A are not useful in diagnosing thyroid follicular tumors'
Mod Pathol, 26 (4), 613-5
DOI 10.1038/modpathol.2013.39, PubMed 23542526

Svare A, Nilsen TI, Asvold BO, Forsmo S, Schei B, Bjøro T, Langhammer A (2013)
Does thyroid function influence fracture risk? Prospective data from the HUNT2 study, Norway
Eur J Endocrinol, 169 (6), 845-52
DOI 10.1530/EJE-13-0546, PubMed 24031093

Publications 2012

Asvold BO, Bjøro T, Platou C, Vatten LJ (2012)
Thyroid function and the risk of coronary heart disease: 12-year follow-up of the HUNT study in Norway
Clin Endocrinol (Oxf), 77 (6), 911-7
DOI 10.1111/j.1365-2265.2012.04477.x, PubMed 22724581

Brydøy M, Fosså SD, Klepp O, Bremnes RM, Wist EA, Bjøro T, Wentzel-Larsen T, Dahl O, Norwegian Urology Cancer Group (NUCG) III study group (2012)
Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer
Br J Cancer, 107 (11), 1833-9
DOI 10.1038/bjc.2012.471, PubMed 23169336

Celestino R, Sigstad E, Løvf M, Thomassen GO, Grøholt KK, Jørgensen LH, Berner A, Castro P, Lothe RA, Bjøro T, Sobrinho-Simões M, Soares P, Skotheim RI (2012)
Survey of 548 oncogenic fusion transcripts in thyroid tumors supports the importance of the already established thyroid fusions genes
Genes Chromosomes Cancer, 51 (12), 1154-64
DOI 10.1002/gcc.22003, PubMed 22961909

Rawal R, Teumer A, Völzke H, Wallaschofski H, Ittermann T, Åsvold BO, Bjøro T, Greiser KH, Tiller D, Werdan K, Meyer zu Schwabedissen HE, Doering A, Illig T, Gieger C, Meisinger C, Homuth G (2012)
Meta-analysis of two genome-wide association studies identifies four genetic loci associated with thyroid function
Hum Mol Genet, 21 (14), 3275-82
DOI 10.1093/hmg/dds136, PubMed 22494929

Aanderud S, Bjøro T (2012)
Thyreoideasykdommer: årsaker, diagnostikk og behandling
Gyldendal akademisk, Oslo (3.utg.)
BIBSYS 080554547, ISBN 978-82-05-38484-2

Publications 2011

Bogsrud TV, Hay ID, Karantanis D, Nathan MA, Mullan BP, Wiseman GA, Kasperbauer JL, Reading CC, Björo T, Lowe VJ (2011)
Prognostic value of 18F-fluorodeoxyglucose-positron emission tomography in patients with differentiated thyroid carcinoma and circulating antithyroglobulin autoantibodies
Nucl Med Commun, 32 (4), 245-51
DOI 10.1097/MNM.0b013e328343a742, PubMed 21278616

Heilo A, Sigstad E, Fagerlid KH, Håskjold OI, Grøholt KK, Berner A, Bjøro T, Jørgensen LH (2011)
Efficacy of ultrasound-guided percutaneous ethanol injection treatment in patients with a limited number of metastatic cervical lymph nodes from papillary thyroid carcinoma
J Clin Endocrinol Metab, 96 (9), 2750-5
DOI 10.1210/jc.2010-2952, PubMed 21715533

Haakensen VD, Bjøro T, Lüders T, Riis M, Bukholm IK, Kristensen VN, Troester MA, Homen MM, Ursin G, Børresen-Dale AL, Helland Å (2011)
Serum estradiol levels associated with specific gene expression patterns in normal breast tissue and in breast carcinomas
BMC Cancer, 11, 332
DOI 10.1186/1471-2407-11-332, PubMed 21812955

Sigstad E, Paus E, Bjøro T, Berner A, Grøholt KK, Jørgensen LH, Sobrinho-Simões M, Holm R, Warren DJ (2011)
The new molecular markers DDIT3, STT3A, ARG2 and FAM129A are not useful in diagnosing thyroid follicular tumors
Mod Pathol, 25 (4), 537-47
DOI 10.1038/modpathol.2011.188, PubMed 22157935

Svare A, Nilsen TI, Bjøro T, Asvold BO, Langhammer A (2011)
Serum TSH related to measures of body mass: longitudinal data from the HUNT Study, Norway
Clin Endocrinol (Oxf), 74 (6), 769-75
DOI 10.1111/j.1365-2265.2011.04009.x, PubMed 21521278

Torfoss D, Sandstad B, Mollnes TE, Høiby EA, Holte H, Bjerner J, Bjøro T, Gaudernack G, Kvalheim G, Kvaløy S (2011)
The mild inflammatory response in febrile neutropenic lymphoma patients with low risk of complications is more pronounced in patients receiving tobramycin once daily compared with three times daily
Scand J Immunol, 74 (6), 632-9
DOI 10.1111/j.1365-3083.2011.02618.x, PubMed 21883353

Åsvold BO, Vatten LJ, Midthjell K, Bjøro T (2011)
Serum TSH within the reference range as a predictor of future hypothyroidism and hyperthyroidism: 11-year follow-up of the HUNT Study in Norway
J Clin Endocrinol Metab, 97 (1), 93-9
DOI 10.1210/jc.2011-1724, PubMed 22049180

Publications 2010

Asvold BO, Bjøro T, Vatten LJ (2010)
Association of thyroid function with estimated glomerular filtration rate in a population-based study: the HUNT study
Eur J Endocrinol, 164 (1), 101-5
DOI 10.1530/EJE-10-0705, PubMed 20930062

Publications 2009

Asvold BO, Bjøro T, Vatten LJ (2009)
Association of serum TSH with high body mass differs between smokers and never-smokers
J Clin Endocrinol Metab, 94 (12), 5023-7
DOI 10.1210/jc.2009-1180, PubMed 19846737

Berg A, Dahl AA, Bruland ØS, Bjøro T, Aanensen MS, Fosså SD (2009)
Definitive radiotherapy with adjuvant long-term antiandrogen treatment for locally advanced prostate cancer: health-related quality of life and hormonal changes
Prostate Cancer Prostatic Dis, 12 (3), 269-76
DOI 10.1038/pcan.2009.8, PubMed 19290019

Bjerner J, Biernat D, Fosså SD, Bjøro T (2009)
Reference intervals for serum testosterone, SHBG, LH and FSH in males from the NORIP project
Scand J Clin Lab Invest, 69 (8), 873-9.e1-11
DOI 10.3109/00365510903380886, PubMed 19929279

Bogsrud TV, Karantanis D, Nathan MA, Mullan BP, Wiseman GA, Kasperbauer JL, Reading CC, Björo T, Hay ID, Lowe VJ (2009)
The prognostic value of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in patients with suspected residual or recurrent medullary thyroid carcinoma
Mol Imaging Biol, 12 (5), 547-53
DOI 10.1007/s11307-009-0276-2, PubMed 19949985

Hellevik AI, Asvold BO, Bjøro T, Romundstad PR, Nilsen TI, Vatten LJ (2009)
Thyroid function and cancer risk: a prospective population study
Cancer Epidemiol Biomarkers Prev, 18 (2), 570-4
DOI 10.1158/1055-9965.EPI-08-0911, PubMed 19155436

Kiserud CE, Fosså A, Bjøro T, Holte H, Cvancarova M, Fosså SD (2009)
Gonadal function in male patients after treatment for malignant lymphomas, with emphasis on chemotherapy
Br J Cancer, 100 (3), 455-63
DOI 10.1038/sj.bjc.6604892, PubMed 19156143

Kiserud CE, Schover LR, Dahl AA, Fosså A, Bjøro T, Loge JH, Holte H, Yuan Y, Fosså SD (2009)
Do male lymphoma survivors have impaired sexual function?
J Clin Oncol, 27 (35), 6019-26
DOI 10.1200/JCO.2009.23.2280, PubMed 19858388

Panicker V, Evans J, Bjøro T, Asvold BO, Dayan CM, Bjerkeset O (2009)
A paradoxical difference in relationship between anxiety, depression and thyroid function in subjects on and not on T4: findings from the HUNT study
Clin Endocrinol (Oxf), 71 (4), 574-80
DOI 10.1111/j.1365-2265.2008.03521.x, PubMed 19751298

Reinertsen KV, Cvancarova M, Wist E, Bjøro T, Dahl AA, Danielsen T, Fosså SD (2009)
Thyroid function in women after multimodal treatment for breast cancer stage II/III: comparison with controls from a population sample
Int J Radiat Oncol Biol Phys, 75 (3), 764-70
DOI 10.1016/j.ijrobp.2008.11.037, PubMed 19286332

Svare A, Nilsen TI, Bjøro T, Forsmo S, Schei B, Langhammer A (2009)
Hyperthyroid levels of TSH correlate with low bone mineral density: the HUNT 2 study
Eur J Endocrinol, 161 (5), 779-86
DOI 10.1530/EJE-09-0139, PubMed 19671706

Publications 2008

Asvold BO, Bjoro T, Nilsen TI, Vatten LJ (2008)
Tobacco smoking and thyroid function: Is weight gain a confounder? Reply
Arch. Intern. Med., 168 (1), 114
DOI 10.1001/archinternmed.2007.20

Asvold BO, Bjoro T, Nilsen TIL, Gunnell D, Vatten LJ (2008)
Thyrotropin Levels and Coronary Heart Disease Mortality In reply
Arch. Intern. Med., 168 (22), 2499
DOI 10.1001/archinternmed.2008.530

Asvold BO, Bjøro T, Nilsen TI, Gunnell D, Vatten LJ (2008)
Thyrotropin levels and risk of fatal coronary heart disease: the HUNT study
Arch Intern Med, 168 (8), 855-60
DOI 10.1001/archinte.168.8.855, PubMed 18443261

Bjerner J, Høgetveit A, Wold Akselberg K, Vangsnes K, Paus E, Bjøro T, Børmer OP, Nustad K (2008)
Reference intervals for carcinoembryonic antigen (CEA), CA125, MUC1, Alfa-foeto-protein (AFP), neuron-specific enolase (NSE) and CA19.9 from the NORIP study
Scand J Clin Lab Invest, 68 (8), 703-13
DOI 10.1080/00365510802126836, PubMed 18609108

Publications 2007

Asvold BO, Bjøro T, Nilsen TI, Vatten LJ (2007)
Association between blood pressure and serum thyroid-stimulating hormone concentration within the reference range: a population-based study
J Clin Endocrinol Metab, 92 (3), 841-5
DOI 10.1210/jc.2006-2208, PubMed 17200168

Asvold BO, Bjøro T, Nilsen TI, Vatten LJ (2007)
Tobacco smoking and thyroid function: a population-based study
Arch Intern Med, 167 (13), 1428-32
DOI 10.1001/archinte.167.13.1428, PubMed 17620538

Asvold BO, Vatten LJ, Nilsen TI, Bjøro T (2007)
The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study
Eur J Endocrinol, 156 (2), 181-6
DOI 10.1530/eje.1.02333, PubMed 17287407

Asvold BO, Vatten LJ, Nilsen TIL, Bjoro T (2007)
The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study (vol 156, pg 181, 2007)
Eur. J. Endocrinol., 156 (6), 707
DOI 10.1530/eje.1.02333e

Brydøy M, Fosså SD, Dahl O, Bjøro T (2007)
Gonadal dysfunction and fertility problems in cancer survivors
Acta Oncol, 46 (4), 480-9
DOI 10.1080/02841860601166958, PubMed 17497315

Liavaag AH, Dørum A, Bjøro T, Oksefjell H, Fosså SD, Tropé C, Dahl AA (2007)
A controlled study of sexual activity and functioning in epithelial ovarian cancer survivors. A therapeutic approach
Gynecol Oncol, 108 (2), 348-54
DOI 10.1016/j.ygyno.2007.10.009, PubMed 17996925

Sigstad E, Heilo A, Paus E, Holgersen K, Grøholt KK, Jørgensen LH, Bogsrud TV, Berner A, Bjøro T (2007)
The usefulness of detecting thyroglobulin in fine-needle aspirates from patients with neck lesions using a sensitive thyroglobulin assay
Diagn Cytopathol, 35 (12), 761-7
DOI 10.1002/dc.20726, PubMed 18008339

Publications 2006

Haukvik UK, Dieset I, Bjøro T, Holte H, Fosså SD (2006)
Treatment-related premature ovarian failure as a long-term complication after Hodgkin's lymphoma
Ann Oncol, 17 (9), 1428-33
DOI 10.1093/annonc/mdl149, PubMed 16831852

Hollender A, Bjøro T, Otto Karlsen K, Kvaloy SO, Nome O, Holte H (2006)
Vitamin D deficiency in patients operated on for gastric lymphoma
Scand J Gastroenterol, 41 (6), 673-81
DOI 10.1080/00365520500356510, PubMed 16716965

Publications 2005

Engum A, Bjøro T, Mykletun A, Dahl AA (2005)
Thyroid autoimmunity, depression and anxiety; are there any connections? An epidemiological study of a large population
J Psychosom Res, 59 (5), 263-8
DOI 10.1016/j.jpsychores.2005.04.002, PubMed 16253615

Fosså SD, Holte H, Holmen MM, Bjøro T, Langmark F, Hess SL, Kvaløy S (2005)
[Long-term effects after mantle field radiotherapy for Hodgkin's lymphoma]
Tidsskr Nor Laegeforen, 125 (1), 41-4
PubMed 15643464

Hagen K, Bjøro T, Zwart JA, Svebak S, Bovim G, Stovner LJ (2005)
Do high TSH values protect against chronic musculoskeletal complaints? The Nord-Trøndelag Health Study (HUNT)
Pain, 113 (3), 416-421
DOI 10.1016/j.pain.2004.11.022, PubMed 15661451

Nord C, Mykletun A, Thorsen L, Bjøro T, Fosså SD (2005)
Self-reported health and use of health care services in long-term cancer survivors
Int J Cancer, 114 (2), 307-16
DOI 10.1002/ijc.20713, PubMed 15543613

Yri OE, Bjoro T, Fossa SD (2005)
Failure to achieve castration levels in patients using leuprolide acetate in locally advanced prostate cancer
Eur Urol, 49 (1), 54-8; discussion 58
DOI 10.1016/j.eururo.2005.09.009, PubMed 16314038

Publications 2004

Bjøro T (2004)
Hypotyreose: en underdiagnostisert og underbehandlet sykdom : resultater fra Helseundersøkelsen i Nord-Trøndelag (HUNT)
[Norges diabetesforbund], [Oslo], Bl. 10-12
BIBSYS 05063948x

Bjøro T, Midthjell K (2004)
Tyreoideasykdom og diabetes mellitus: resultater fra Helseundersøkelsen i Nord-Trøndelag (HUNT)
[Norges diabetesforbund], [Oslo], Bl. 14-16
BIBSYS 050639439

Publications 2003

Bjøro K, Brandsaeter B, Wiencke K, Bjøro T, Godang K, Bollerslev J, Schrumpf E (2003)
Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease
Scand J Gastroenterol, 38 (3), 320-7
DOI 10.1080/00365520310000681, PubMed 12737449

Bjøro K, Brandsæter B, Wiencke K, Bjøro T, Godang K, Bollerslev J, Schrumpf E (2003)
Secondary Osteoporosis in Liver Transplant Recipients: a Longitudinal Study in Patients With and Without Cholestatic Liver Disease
Scand J Gastroenterol, 38 (3), 320-327
DOI 10.1080/00365520310000681, PubMed 28248598

Bjøro K, Brandsæter B, Wiencke K, Bjøro T, Godang K, Bollerslev J, Schrumpf E (2003)
Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease
In Scandinavian journal of gastroenterology, Taylor & Francis, Basingstoke, 38(2003)3, s.320-7
BIBSYS 041707508

Nord C, Bjøro T, Ellingsen D, Mykletun A, Dahl O, Klepp O, Bremnes RM, Wist E, Fosså SD (2003)
Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer
Eur Urol, 44 (3), 322-8
DOI 10.1016/s0302-2838(03)00263-x, PubMed 12932930

Raastad T, Glomsheller T, Bjøro T, Hallén J (2003)
Recovery of skeletal muscle contractility and hormonal responses to strength exercise after two weeks of high-volume strength training
Scand J Med Sci Sports, 13 (3), 159-68
DOI 10.1034/j.1600-0838.2003.00297.x, PubMed 12753488

Raastad T, Glomsheller T, Bjøro T, Hallén J (2003)
Recovery of skeletal muscle contractility and hormonal responses to strength exercise after two weeks of high-volume strength training
In Scandinavian journal of medicine & science in sports, Munksgaard., Copenhagen, 13(2003)3, s.159-68
BIBSYS 041726170

Publications 2002

Bjøro T, Holmen J, Krüger Ø, Midthjell K, Hunstad K, Schreiner T, Sandnes L, Brochmann H (2002)
[Prevalence of hypothyroidism and hyperthyroidism in Nord-Trondelag]
Tidsskr Nor Laegeforen, 122 (10), 1022-8
PubMed 12082694

Dalgard O, Bjøro K, Hellum K, Myrvang B, Bjøro T, Haug E, Bell H (2002)
Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha: no association with either interferon dosage or efficacy of therapy
J Intern Med, 251 (5), 400-6
DOI 10.1046/j.1365-2796.2002.00974.x, PubMed 11982739

Dalgard O, Bjøro K, Hellum K, Myrvang B, Bjøro T, Haug E, Bell H (2002)
Thyroid dysfunction during treatment of chronic hepatitisC with interferon alpha: no association with wither dosage or efficacy of therapy
In Journal of internal medicine, Blackwell Scientific Publ., Oxford, 251(2002)nr 5, s. 400-406
BIBSYS 031206328

Engum A, Bjøro T, Mykletun A, Dahl AA (2002)
An association between depression, anxiety and thyroid function--a clinical fact or an artefact?
Acta Psychiatr Scand, 106 (1), 27-34
DOI 10.1034/j.1600-0447.2002.01250.x, PubMed 12100345

Engum A, Bjøro T, Mykletun A, Dahl AA (2002)
An association between depression, anxiety and thyroid function - a clinical fact or an artefact?
In Acta psychiatrica Scandinavica, Munksgaard, Copenhagen, 106(2002)nr 1, s. 27-34
BIBSYS 031281966

Fodstad P, Bjøro T, Torlakovic G, Fossa SD (2002)
No association of serum gonadal or pituitary hormones with prognostic parameters in stages T1 to T3 PN0M0 prostate cancer
J Urol, 168 (3), 1188-92
DOI 10.1016/S0022-5347(05)64623-X, PubMed 12187265

Holmen J, Krüger Ø, Midthjell K, Bjøro T (2002)
Prevalens av hypotyreose og hypertyreose i Nord-Trøndelag
[Den Norske lægeforening], [Oslo], Bl. 1022-1028
BIBSYS 040615049

Aanderud S, Bjøro T (2002)
Thyreoideasykdommer: årsaker, diagnostikk og behandling
Gyldendal akademisk, Oslo (2. utg.), 139 s.
BIBSYS 020405308, ISBN 82-05-28071-1

Publications 2001

Bjerke SN, Bjøro T, Heyerdahl S (2001)
[Psychiatric and cognitive aspects of hypothyroidism]
Tidsskr Nor Laegeforen, 121 (20), 2373-6
PubMed 11603044

Bjerke SN, Bjøro T, Heyerdahl S (2001)
Psykiatriske og kognitive aspekter ved hypotyreose
In Tidsskrift for Den norske legeforening, Foreningen, Oslo, 121(2001)nr. 20, S. 2373-2376
BIBSYS 022054766

Hagen K, Bjøro T, Zwart JA, Vatten L, Stovner LJ, Bovim G (2001)
Low headache prevalence amongst women with high TSH values
Eur J Neurol, 8 (6), 693-9
DOI 10.1046/j.1468-1331.2001.00310.x, PubMed 11784355

Hagen K, Bjøro T, Zwart JA, Vatten L, Stovner LJ, Bovim G (2001)
Low headache prevalence amongst women with high TSH values
In European journal of neurology, Rapid Science, Oxford, 8(2001)nr 6, s.693-699
BIBSYS 022055673

Johansen PW, Paulssen RH, Bjøro T, Gautvik KM, Gordeladze JO (2001)
Distinct guanine nucleotide binding protein alpha-subunit receptor coupling in GH cell lines: effects of bromocriptine and hormones on effector enzyme modulation
Cell Physiol Biochem, 11 (6), 339-52
DOI 10.1159/000047820, PubMed 11832659

Johansen PW, Paulssen RH, Bjøro T, Gautvik KM, Gordeladze JO (2001)
Distinct guanine nucleotide binding protein alpha-subunitreceptor coupling in GH cell lines: effects of bromocriptineand hormones on effector enzyme modulation
In Cellular physiology and biochemistry, Karger, Basel, 11(2001)nr 6, s.339-352
BIBSYS 022056629

Raastad T, Glomsheller T, Bjøro T, Hallén J (2001)
Changes in human skeletal muscle contractility and hormone status during 2 weeks of heavy strength training
Eur J Appl Physiol, 84 (1-2), 54-63
DOI 10.1007/s004210000328, PubMed 11394254

Raastad T, Glomsheller T, Bjøro T, Hallén J (2001)
Changes in human skeletal muscle contractility and hormone status during 2 weeks of heavy strength training
In European journal of applied physiology, Springer, Berlin, 84(2001)nr 1-2, s.54-63
BIBSYS 022058974

Publications 2000

Bjoro T, Holmen J, Krüger O, Midthjell K, Hunstad K, Schreiner T, Sandnes L, Brochmann H (2000)
Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT)
Eur J Endocrinol, 143 (5), 639-47
DOI 10.1530/eje.0.1430639, PubMed 11078988

Ostberg BC, Sand O, Bjøro T, Haug E (2000)
Perfusion system for studying peptide secretion from endocrine cells with high time resolution
Biotechniques, 29 (5), 1114-8, 1120, 1122-5
DOI 10.2144/00295rr08, PubMed 11084875

Raastad T, Bjøro T, Hallén J (2000)
Hormonal responses to high- and moderate-intensity strength exercise
Eur J Appl Physiol, 82 (1-2), 121-8
DOI 10.1007/s004210050661, PubMed 10879453

Raastad T, Bjøro T, Hallén J (2000)
Hormonal responses to high- and moderate-intensity strength exercise
In European journal of applied physiology, Springer, Berlin, 82(2000)nr 1-2, s.121-128
BIBSYS 010830359

Østberg BC, Sand O, Bjøro T, Haug E (2000)
Perfusion system for studying peptide secretion from endocrine cells wi th high time resolution
In Biotechniques, Eaton Publishing Co., Natick, MA, S. 1114-8,1120,1122-5
BIBSYS 010893229

Publications 1998

Stoppard M, Bjøro T (1998)
Barnets helse fra A til Å
Gyldendal fakta, Oslo (3. utg.), 317 s.
BIBSYS 980907985, ISBN 82-05-25170-3

Publications 1997

Bernstein R, Midtbø K, Urdal P, Mørkrid L, Smith G, Muller C, Bjøro T, Haug E (1997)
Serum N-terminal pro-atrial natriuretic factor 1-98 before and during thyroxine replacement therapy in severe hypothyroidism
Thyroid, 7 (3), 415-9
DOI 10.1089/thy.1997.7.415, PubMed 9226213

Unneberg K, Mjaaland M, Balteskard L, Jenssen TG, Bjøro T, Revhaug A (1997)
Both growth hormone and exogenous glutamine increase gastrointestinal glutamine uptake in trauma
Ann Surg, 225 (1), 97-102
DOI 10.1097/00000658-199701000-00011, PubMed 8998125

Publications 1996

Torjesen PA, Bjøro T (1996)
Antibodies against [125I] testosterone in patient's serum: a problem for the laboratory and the patient
Clin Chem, 42 (12), 2047-8
PubMed 8969653

Aanderud S, Bjøro T (1996)
Thyreoideasykdommer: årsaker, diagnostikk og behandling
Universitetsforl., Oslo, 108 s.
BIBSYS 96081972x, ISBN 82-00-42003-5

Publications 1995

Bjøro T, Mørkrid L, Wergeland R, Turter A, Kvistborg A, Sand T, Torjesen P (1995)
Frequency of hyperprolactinaemia due to large molecular weight prolactin (150-170 kD PRL)
Scand J Clin Lab Invest, 55 (2), 139-47
DOI 10.3109/00365519509089606, PubMed 7667607

Mjaaland M, Unneberg K, Jenssen TG, Bjøro T, Lindal S, Revhaug A (1995)
Metabolic effects of two regimens of growth hormone given before operation in piglets
Eur J Surg, 161 (9), 639-46
PubMed 8541422

Publications 1994

Berg JP, Liane KM, Bjørhovde SB, Bjøro T, Torjesen PA, Haug E (1994)
Vitamin D receptor binding and biological effects of cholecalciferol analogues in rat thyroid cells
J Steroid Biochem Mol Biol, 50 (3-4), 145-50
DOI 10.1016/0960-0760(94)90021-3, PubMed 8049143

Berg JP, Sandvik JA, Ree AH, Sørnes G, Bjøro T, Torjesen PA, Gordeladze JO, Haug E (1994)
1,25-Dihydroxyvitamin D3 attenuates adenylyl cyclase activity in rat thyroid cells: reduction of thyrotropin receptor number and increase in guanine nucleotide-binding protein Gi-2 alpha
Endocrinology, 135 (2), 595-602
DOI 10.1210/endo.135.2.8033808, PubMed 8033808

Sørnes S, Bjøro T, Berg JP, Torjesen PA, Haug E (1994)
Calcitriol attenuates the basal and vasoactive intestinal peptide-stimulated cAMP production in prolactin-secreting rat pituitary (GH4C1) cells
Mol Cell Endocrinol, 101 (1-2), 183-8
DOI 10.1016/0303-7207(94)90233-x, PubMed 9397951

Publications 1993

Bjøro T, Englund K, Torjesen PA, Haug E (1993)
Inhibitors of the arachidonic acid metabolism attenuate the thyroliberin (TRH) stimulated prolactin production without modifying the production of inositolphosphates in GH4C1 pituitary cells
Scand J Clin Lab Invest, 53 (2), 111-6
DOI 10.3109/00365519309088397, PubMed 8469910

Bjøro T, Johansen E, Frey HH, Turter A, Torjesen PA (1993)
Different responses in little and bigbig prolactin to metoclopramide in subjects with hyperprolactinemia due to 150-170 kD (bigbig) prolactin
Acta Endocrinol (Copenh), 128 (4), 308-12
DOI 10.1530/acta.0.1280308, PubMed 8498149

Kvistborg A, Halse J, Bakke S, Bjøro T, Hansen E, Djøseland O, Brownell J, Jervell J (1993)
Long-term treatment of macroprolactinomas with CV 205-502
Acta Endocrinol (Copenh), 128 (4), 301-7
DOI 10.1530/acta.0.1280301, PubMed 8098891

Mjaaland M, Unneberg K, Bjøro T, Revhaug A (1993)
Growth hormone treatment after abdominal surgery decreased carbohydrate oxidation and increased fat oxidation in patients with total parenteral nutrition
Metabolism, 42 (2), 185-90
DOI 10.1016/0026-0495(93)90033-k, PubMed 8474315

Aanestad M, Røtnes JS, Torjesen PA, Haug E, Sand O, Bjøro T (1993)
Epidermal growth factor stimulates the prolactin synthesis and secretion in rat pituitary cells in culture (GH4C1 cells) by increasing the intracellular concentration of free calcium
Acta Endocrinol (Copenh), 128 (4), 361-6
DOI 10.1530/acta.0.1280361, PubMed 8388615

Publications 1992

Bjøro T, Larsen V, Englund K, Torjesen PA, Haug E (1992)
The lipoxygenase inhibitor nafazatrom inhibits stimulated prolactin secretion in cultured rat lactotrophs (GH4C1 cells)
Scand J Clin Lab Invest, 52 (4), 297-303
DOI 10.3109/00365519209088362, PubMed 1332181

Dahl-Jørgensen K, Bjøro T, Kierulf P, Sandvik L, Bangstad HJ, Hanssen KF (1992)
Long-term glycemic control and kidney function in insulin-dependent diabetes mellitus
Kidney Int, 41 (4), 920-3
DOI 10.1038/ki.1992.140, PubMed 1513113

Publications 1990

Bjøro T, Sand O, Ostberg BC, Gordeladze JO, Torjesen P, Gautvik KM, Haug E (1990)
The mechanisms by which vasoactive intestinal peptide (VIP) and thyrotropin releasing hormone (TRH) stimulate prolactin release from pituitary cells
Biosci Rep, 10 (2), 189-99
DOI 10.1007/BF01116578, PubMed 2162702

Jacobsen TF, Sand O, Bjøro T, Karlsen HE, Iversen JG (1990)
Effect of Diamphidia toxin, a Bushman arrow poison, on ionic permeability in nucleated cells
Toxicon, 28 (4), 435-44
DOI 10.1016/0041-0101(90)90082-i, PubMed 2161574

Tanbo T, Abyholm T, Bjøro T, Dale PO (1990)
Ovarian stimulation in previous failures from in-vitro fertilization: distinction of two groups of poor responders
Hum Reprod, 5 (7), 811-5
DOI 10.1093/oxfordjournals.humrep.a137188, PubMed 2125056

Publications 1989

Bjøro T, Frey HM, Larsen IF, Brochmann H, Hanson F, Gaarder PI (1989)
[Thyroid dysfunction and thyroid antibodies in a population group over the age of 70. A prevalence study from Oslo and Naeröy]
Tidsskr Nor Laegeforen, 109 (10), 1048-51
PubMed 2786266

Gordeladze JO, Björo T, Torjesen PA, Ostberg BC, Haug E, Gautvik KM (1989)
Protein kinase C stimulates adenylate cyclase activity in prolactin-secreting rat adenoma (GH4C1) pituicytes by inactivating the inhibitory GTP-binding protein Gi
Eur J Biochem, 183 (2), 397-406
DOI 10.1111/j.1432-1033.1989.tb14941.x, PubMed 2569396

Sand O, Chen B, Li Q, Karlsen HE, Bjøro T, Haug E (1989)
Vasoactive intestinal peptide (VIP) may reduce the removal rate of cytosolic Ca2+ after transient elevations in clonal rat lactotrophs
Acta Physiol Scand, 137 (1), 113-23
DOI 10.1111/j.1748-1716.1989.tb08727.x, PubMed 2552748

Publications 1988

Bjøro T (1988)
Regulation of prolactin secretion from rat lactotrophs: the mechanism of action of vasoactive intestinal peptide (VIP) and other hypothalamic hormones
Aker Hospital, Hormone Laboratory, Oslo, 1 b. (flere pag.)
BIBSYS 884157261

Bjøro T, Ostberg BC, Sand O, Torjesen PA, Penman E, Gordeladze JO, Iversen JG, Gautvik KM, Haug E (1988)
Somatostatin inhibits prolactin secretion by multiple mechanisms involving a site of action distal to increased cyclic adenosine 3',5'-monophosphate and elevated cytosolic Ca2+ in rat lactotrophs
Acta Physiol Scand, 133 (3), 271-82
DOI 10.1111/j.1748-1716.1988.tb08408.x, PubMed 2906508

Brochmann H, Bjøro T, Gaarder PI, Hanson F, Frey HM (1988)
Prevalence of thyroid dysfunction in elderly subjects. A randomized study in a Norwegian rural community (Naerøy)
Acta Endocrinol (Copenh), 117 (1), 7-12
DOI 10.1530/acta.0.1170007, PubMed 3381628

Dahl-Jørgensen K, Hanssen KF, Kierulf P, Bjøro T, Sandvik L, Aagenaes O (1988)
Reduction of urinary albumin excretion after 4 years of continuous subcutaneous insulin infusion in insulin-dependent diabetes mellitus. The Oslo Study
Acta Endocrinol (Copenh), 117 (1), 19-25
DOI 10.1530/acta.0.1170019, PubMed 3289293

Gordeladze JO, Bjøro T, Ostberg BC, Sand O, Torjesen P, Haug E, Gautvik KM (1988)
Phorbol esters and thyroliberin have distinct actions regarding stimulation of prolactin secretion and activation of adenylate cyclase in rat pituitary tumour cells (GH4C1 cells)
Biochem Pharmacol, 37 (16), 3133-8
DOI 10.1016/0006-2952(88)90311-5, PubMed 2900008

JORGENSEN KD, HANSSEN KF, KIERULF P, BJORO T, SANDVIK L, AAGENAES O (1988)
REDUCTION OF URINARY ALBUMIN EXCRETION AFTER 4 YEARS OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IN INSULIN-DEPENDENT DIABETES-MELLITUS - THE OSLO STUDY
Diabetes Metab., 14 (2BIS), 220-221

Torjesen PA, Bjøro T, Ostberg BC, Haug E (1988)
Thyrotropin-releasing hormone-stimulated inositol trisphosphate formation is liable to thyrotropin-releasing hormone-induced desensitization by a calcium-dependent mechanism
Mol Cell Endocrinol, 56 (1-2), 107-14
DOI 10.1016/0303-7207(88)90014-7, PubMed 3131167

Publications 1987

Bjøro T, Ostberg BC, Sand O, Gordeladze J, Iversen JG, Torjesen PA, Gautvik KM, Haug E (1987)
Vasoactive intestinal peptide and peptide with N-terminal histidine and C-terminal isoleucine increase prolactin secretion in cultured rat pituitary cells (GH4C1) via a cAMP-dependent mechanism which involves transient elevation of intracellular Ca2+
Mol Cell Endocrinol, 49 (2-3), 119-28
DOI 10.1016/0303-7207(87)90205-x, PubMed 2435588

Bjøro T, Torjesen PA, Ostberg BC, Sand O, Iversen JG, Gautvik KM, Haug E (1987)
Bombesin stimulates prolactin secretion from cultured rat pituitary tumour cells (GH4C1) via activation of phospholipase C
Regul Pept, 19 (3-4), 169-82
DOI 10.1016/0167-0115(87)90274-6, PubMed 2829290

Bjøro T, Wiik P, Opstad PK, Gautvik KM, Haug E (1987)
Binding and degradation of vasoactive intestinal peptide in prolactin-producing cultured rat pituitary tumour cells (GH4C1)
Acta Physiol Scand, 130 (4), 609-18
DOI 10.1111/j.1748-1716.1987.tb08183.x, PubMed 2820199

Blomhoff HK, Smeland EB, Beiske K, Blomhoff R, Ruud E, Bjøro T, Pfeifer-Ohlsson S, Watt R, Funderud S, Godal T (1987)
Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes
J Cell Physiol, 131 (3), 426-33
DOI 10.1002/jcp.1041310315, PubMed 3036888

Griffiths D, Bjøro T, Gautvik K, Haug E (1987)
Melatonin reduces the production and secretion of prolactin and growth hormone from rat pituitary cells in culture
Acta Physiol Scand, 131 (1), 43-9
DOI 10.1111/j.1748-1716.1987.tb08203.x, PubMed 2823532

Haug E, Bjøro T, Gautvik KM (1987)
A permissive role for extracellular Ca2+ in regulation of prolactin production by 1,25-dihydroxyvitamin D3 in GH3 pituitary cells
J Steroid Biochem, 28 (4), 385-91
DOI 10.1016/0022-4731(87)91055-7, PubMed 2889849

Publications 1986

Ostberg BC, Sand O, Bjøro T, Haug E (1986)
The phorbol ester TPA induces hormone release and electrical activity in clonal rat pituitary cells
Acta Physiol Scand, 126 (4), 517-24
DOI 10.1111/j.1748-1716.1986.tb07850.x, PubMed 3087138

Publications 1984

Bjøro T, Gaarder PI, Smeland EB, Kornstad L (1984)
Thyroid antibodies in blood donors: prevalence and clinical significance
Acta Endocrinol (Copenh), 105 (3), 324-9
DOI 10.1530/acta.0.1050324, PubMed 6702401

Bjøro T, Haug E, Sand O, Gautvik KM (1984)
Vasoactive intestinal peptide causes a calcium-dependent stimulation of prolactin secretion in GH4C1 cells
Mol Cell Endocrinol, 37 (1), 41-50
DOI 10.1016/0303-7207(84)90126-6, PubMed 6432604

Publications 1982

Bjøro T (1982)
[Hemorrhaging corpus luteum. An important cause of acute abdomen in young women]
Tidsskr Nor Laegeforen, 102 (12), 681-3
PubMed 7157246